These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20543471)

  • 1. [Cost-benefit of expanding cervical cancer screening].
    Deng J; Tan H; Yang T; Huang X; Zhou S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 May; 35(5):470-5. PubMed ID: 20543471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Costs and problems in cervix cancer screening are considerably underestimated].
    Bistoletti P
    Lakartidningen; 2000 Aug; 97(32-33):3506-8. PubMed ID: 11037597
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of cervical-cancer screening in developing countries.
    Suba EJ; Frable WJ; Raab SS
    N Engl J Med; 2006 Apr; 354(14):1535-6; author reply 1535-6. PubMed ID: 16598056
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cervix cancer screening: results of a french team].
    Salvat J; Slamani L; Schmidt MH
    Rev Med Suisse Romande; 1997 Aug; 117(8):593-6. PubMed ID: 9340713
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cervix cancer screening can be cost-effective. Combination of vaginal smears and the HPV test should be even more beneficial].
    Bistoletti P; Ellström A; Dillner J; Sennfält K; Sparén P; Strander B
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1874-6, 1878-9. PubMed ID: 16044766
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for cervical neoplasia. A survey of the assumptions from studies on the screening in Maribo Amt.
    Berget A
    Dan Med Bull; 1979 Nov; 26(7):313-32. PubMed ID: 118850
    [No Abstract]   [Full Text] [Related]  

  • 7. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
    Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
    Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost effectiveness analysis of screening strategies for cervical cancer in Tunisia].
    Lazaar HB; Aounallah-Skhiri H; Oueslati F; Frikha H; Achour N; Hsairi M
    East Mediterr Health J; 2010 Jun; 16(6):602-8. PubMed ID: 20799586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical screening in general practice: call and recall.
    Ridsdale LL
    J R Coll Gen Pract; 1987 Jun; 37(299):257-9. PubMed ID: 3129556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Present status of cytological screening for cervix neoplasms].
    Naujoks H
    Gynakologe; 1981 Dec; 14(4):204-11. PubMed ID: 6797874
    [No Abstract]   [Full Text] [Related]  

  • 11. [Is cervical screening justified in adolescents?].
    Barrasso R; Monsonego J
    Contracept Fertil Sex; 1996 Feb; 24(2):101-3. PubMed ID: 8611929
    [No Abstract]   [Full Text] [Related]  

  • 12. [A reply on cervix cancer screening: cervical cytological test doesn't fulfil the requirements of a good screening test].
    Bistoletti P
    Lakartidningen; 2000 Sep; 97(37):4042. PubMed ID: 11036367
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cost-benefit analysis of the Program for Early Screening of Cervico-uterine Cancer].
    Hernández-Peña P; Lazcano-Ponce EC; Alonso-de Ruiz P; Cruz-Valdez A; Meneses-González F; Hernández-Avila M
    Salud Publica Mex; 1997; 39(4):379-87. PubMed ID: 9381251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cervical cancer screening and associated treatment costs in France].
    Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V
    Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is human papillomavirus screening preferable to current policies in vaccinated and unvaccinated women? A cost-effectiveness analysis.
    Accetta G; Biggeri A; Carreras G; Lippi G; Carozzi FM; Confortini M; Zappa M; Paci E
    J Med Screen; 2010; 17(4):181-9. PubMed ID: 21258128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality control in cervical cancer screening: Brazilian experience.
    Collaço LM; de Noronha L; Bleggi-Torres LF; Pinheiro DL
    Acta Cytol; 2005; 49(6):694-6. PubMed ID: 16450916
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving the sensitivity of cervical cytology: what are the issues?
    Myers ER
    Am J Manag Care; 2000 Jul; 6(7):838-40. PubMed ID: 11067380
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cost effectiveness of cervical cancer screening strategies in Tunisia].
    Hsaïri M; Fakhfakh R; Ghyoula M; Ben Abdallah M; Achour N
    Tunis Med; 2000 Oct; 78(10):557-61. PubMed ID: 11190738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical inquiries. Should we discontinue Pap smear screening in women aged>65 years?
    Curran DR; Stigleman S; Neher JO
    J Fam Pract; 2004 Apr; 53(4):308-10. PubMed ID: 15068776
    [No Abstract]   [Full Text] [Related]  

  • 20. Economics of screening for cancer of the cervix.
    Hicks S; Edwards D
    N Z Med J; 1986 Nov; 99(814):916. PubMed ID: 3468422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.